IV Disinfecting Caps Market Overview
IV Disinfecting Caps Market is looking forward to grow at a higher rate in the forecast period of 2021-2031. It is estimated that nearly, 32.0% of HAIs are urinary tract infections (UTIs), 22.0% are surgical site infections (SSIs), 15.0% are pneumonia, and 14.0% are bloodstream infections (BSIs). IV caps are most useful in avoiding hospital acquired infections and helps hospital staff to protect themselves.
The IV disinfecting caps market is said to grow steadily as the increase in number of hospital admissions and infections that can be easily affected to the people in it. Society for Healthcare Epidemiology of America (SHEA) and other top infection-control organizations in 2014 recognized the use of disinfection caps for hospitals.
What is driving Demand for IV Disinfecting Caps Market?
The demand for IV Disinfecting Caps Market has seen at a higher rate at a global level as there has increase in the number of diseases that leads into surgery. Furthermore, the rising ageing population and lack of hygiene is expected to drive the market. According to a CDC report in 2018, around 1.7 million cases of HAIs and around 99,000 associated deaths are reported each year in American hospitals.
Precautions and sanitation measures have been driving the market at a pace. Globally, this diseases are more prone towards people with low immunity. The demand of IV Disinfecting Caps Market is on to the higher as Government is indulging into keeping the hospitals clean to avoid HAIs.
Rise in cancer deaths every year has brought attention to parenteral nutrition, says WHO which leads to increase in demand for the IV Connectors. These reasons have said to be the driving factors for the market in the given forecast period 2021-2031.
U.S. IV Disinfecting Caps Market Outlook
U.S. is said to be the most dominating in terms of disease growth rate and will be the top one to boost the IV Disinfecting Caps Market. This is due to the rising number in the health diseases, and immunocompromised patients. According to CDC histoplasmosis is the commonest disease seen in HIV/ AIDS patients and due to their immunocompromised state 30% of them result in death.
This can be an opportunistic driving factor for the treatment market to grow. In addition, rising R&D and technological advancement in the region are some of the drivers of IV Disinfecting Caps Market. Ivera Medical Corporation, got approved with its Curos® disinfecting port protector, in January 2012, and it has been taking efforts in constantly improving its product. ICU Medical signed definitive agreement to acquire Pursuit Vascular, Inc. in January 2008.
Europe Demand Outlook for IV Disinfecting Caps Market
European Centre for Disease Prevention and Control (ECDC) in 2018, prevalence of HAIs in European countries was around 7.1%. It also reported that around 4,131,000 patients suffer from HAIs in Europe each year. The increasing focus on the healthcare facility, increase in the population of above 65 age group is likely to drive the market growth.
Furthermore, the growing chronic diseases which diminishes the immunity of a person and AIDS in the region are boosting the demand of IV Disinfecting Caps Market. Centre’s for Disease Control and Prevention (CDC), about 1 in 25 hospital patients has at least one healthcare-associated infection, on any given day. This has hiked the growth of the demand of disinfecting caps.
Who are the Key Manufacturers and Suppliers of IV Disinfecting Caps Market?
Some of the key players operating in the IV Disinfecting Caps Market are
- Phenomenome Discoveries Inc.
- Human Metabolome Technologies, Inc.
- Thermo Fisher Scientific, Inc.,
- Bio- Rad Laboratories, Inc.
- Biocrates Life Sciences AG
- Agilent Technologies, Inc
- Merit Medical
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
By Product Type:
- Single Cap
- Double Cap
By End User:
- Diagnostic Centre’s
- Blood Collection,
- Blood Transfusion
- North America
- Latin America
- South Asia
- East Asia
- Middle East and Africa